Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy

American Journal of Nephrology

Volumn 33, Issue 6, 2011, Pages 537-549

  Asanuma, Katsuhiko ^a   Akiba Takagi, Miyuki ^a   Kodama, Fumiko ^a   Asao, Rin ^a   Nagai, Yoshiko ^a   Lydia, Aida ^a,c   Fukuda, Hiromitsu ^a   Tanaka, Eriko ^a,b   Shibata, Terumi ^a   Takahara, Hisatsugu ^a   Hidaka, Teruo ^a   Asanuma, Etsuko ^a   Kominami, Eiki ^a   Ueno, Takashi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

Author keywords

Adriamycin mice; Apoptosis; Dendrin; Glomerulosclerosis; Nephrosis; Podocyte

Indexed keywords

BINDING PROTEIN; DENDRIN; DOXORUBICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; MOUSE; NEPHROSIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; WESTERN BLOTTING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL NUCLEUS; CELLS, CULTURED; DOXORUBICIN; FEMALE; GLOMERULAR BASEMENT MEMBRANE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MICE; MICE, INBRED BALB C; NEPHROSIS; NERVE TISSUE PROTEINS; PODOCYTES; PROTEINURIA; RATS;

EID: 79956203805     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000327995     Document Type: Article

References (35)

1. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 2002;13:3005-3015. (Pubitemid 35386921)
2. Somlo S, Mundel P: Getting a foothold in nephrotic syndrome. Nat Genet 2000;24:333-335. (Pubitemid 30187426)
3. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931-938.
4. Shankland SJ: The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131-2147. (Pubitemid 43882099)
5. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005;67: 404-419. (Pubitemid 40139832)
6. Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley AN: Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 2001;12:1422-1433. (Pubitemid 32666325)
7. Caulfield JP, Reid IT, Farquhar MG: Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occludingjunctions and epithelial cell detachment. Lab Invest 1976;34:43-59.
8. Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, Sakai T: Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis. Kidney Int 1996;50: 1278-1287. (Pubitemid 26342820)
9. Hishiki T, Shirato I, Takahashi Y, Funabiki K, Horikoshi S, Tomino Y: Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 2001;24: 99-104. (Pubitemid 32642062)
10. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-348. (Pubitemid 27053474)
11. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001;60:957-968. (Pubitemid 34205795)
12. Lemley KV: Diabetes and chronic kidney disease: lessons from the Pima Indians. Pe-diatr Nephrol 2008;23:1933-1940.
13. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD: Podocyto-penia and disease severity in IgA nephropathy. Kidney Int 2002;61:1475-1485. (Pubitemid 34304509)
14. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 1982;46:16-23. (Pubitemid 12167012)
15. Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z: Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol 2005; 289:F880-F890. (Pubitemid 41324209)
16. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P: Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113: 1390-1397. (Pubitemid 39071694)
17. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH: Experimental focal segmental glomerulosclerosis in mice. Nephron 1998;78:440-452. (Pubitemid 28154166)
18. Lee VW, Harris DC: Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 2011;16:30-38.
19. Neuner-Jehle M, Denizot JP, Borbely AA, Mallet J: Characterization and sleep deprivation-induced expression modulation of dendrin, a novel dendritic protein in rat brain neurons. J Neurosci Res 1996;46:138-151. (Pubitemid 26367539)
20. Asanuma K, Campbell KN, Kim K, Faul C, Mundel P: Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. Proc Natl Acad Sci USA 2007;104:10134-10139. (Pubitemid 47175275)
21. Duner F, Patrakka J, Xiao Z, Larsson J, Vlamis-Gardikas A, Pettersson E, Tryggvason K, Hultenby K, Wernerson A: Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome. Nephrol Dial Transplant 2008; 23:2504-2511.
22. Tanimoto M, Gohda T, Kaneko S, Hagiwara S, Murakoshi M, Aoki T, Yamada K, Ito T, Matsumoto M, Horikoshi S, Tomino Y: Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. Metabolism 2007;56:160-167. (Pubitemid 46074060)
23. Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, Faul C, Reiser J, Mundel P: Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 2005;115:1188-1198. (Pubitemid 40629037)
24. Tanimoto M, Fan Q, Gohda T, Shike T, Makita Y, Tomino Y: Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice. Metabolism 2004;53: 1473-1479. (Pubitemid 39410389)
25. Asanuma K, Tanida I, Shirato I, Ueno T, Takahara H, Nishitani T, Kominami E, Tomino Y: MAP-LC3, a promising autophago-somal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J 2003;17:1165-1167.
26. Kanamaru Y, Tamouza H, Pfirsch S, El-Mehdi D, Guerin-Marchand C, Pretolani M, Blank U, Monteiro RC: IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth. Blood 2007;109:203-211. (Pubitemid 46070122)
27. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, Kerjaschki D, Holthofer H: Nephrin in experimental glomerular disease. Kidney Int 2000;58:1461-1468.
28. Kawachi H, Koike H, Kurihara H, Sakai T, Shimizu F: Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 2003;14:46-56. (Pubitemid 36026296)
29. Guo J, Ananthakrishnan R, Qu W, Lu Y, Reiniger N, Zeng S, Ma W, Rosario R, Yan SF, Ramasamy R, D'Agati V, Schmidt AM: RAGE mediates podocyte injury in adria-mycin-induced glomerulosclerosis. J Am Soc Nephrol 2008; 19:961-972.
30. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K: Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 2005; 16:2690-2701.
31. Murea M, Park JK, Sharma S, Kato H, Gruenwald A, Niranjan T, Si H, Thomas DB, Pullman JM, Melamed ML, Susztak K: Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 2010;78:514-522.
32. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P: Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17:428-437. (Pubitemid 47499042)
33. Benzing T: Signaling at the slit diaphragm. J Am Soc Nephrol 2004;15:1382-1391. (Pubitemid 38679663)
34. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Burner C, Pavenstadt H, Shaw AS, Walz G, Benzing T: Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003;23:4917-4928. (Pubitemid 36793337)
35. Schiffer M, Mundel P, Shaw AS, Bottinger EP: A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J Biol Chem 2004;279:37004-37012. (Pubitemid 39129050)